Decentralised Procedure Public Assessment Report Bilaxten 10 mg Schmelztabletten Bilaxten 2,5 mg / ml Lösung zum Einnehmen Anti
![WO2019097090A1 - Pharmaceutical tablet composition comprising bilastine and magnesium aluminometasilicate - Google Patents WO2019097090A1 - Pharmaceutical tablet composition comprising bilastine and magnesium aluminometasilicate - Google Patents](https://patentimages.storage.googleapis.com/92/d0/7c/8a06a4a03ca18b/imgf000038_0003.png)
WO2019097090A1 - Pharmaceutical tablet composition comprising bilastine and magnesium aluminometasilicate - Google Patents
![WO2019097090A1 - Pharmaceutical tablet composition comprising bilastine and magnesium aluminometasilicate - Google Patents WO2019097090A1 - Pharmaceutical tablet composition comprising bilastine and magnesium aluminometasilicate - Google Patents](https://patentimages.storage.googleapis.com/ba/dd/06/4cc41bec10219d/imgf000052_0001.png)
WO2019097090A1 - Pharmaceutical tablet composition comprising bilastine and magnesium aluminometasilicate - Google Patents
![WO2019097090A1 - Pharmaceutical tablet composition comprising bilastine and magnesium aluminometasilicate - Google Patents WO2019097090A1 - Pharmaceutical tablet composition comprising bilastine and magnesium aluminometasilicate - Google Patents](https://patentimages.storage.googleapis.com/d4/43/0c/696b60ac9523fd/imgf000035_0002.png)